The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
<p><strong>Background</strong> Cryptococcal meningitis has fatality rates of 40%‐70%, resulting in 200 000 deaths each year. The best outcomes are achieved with amphotericin combined with flucytosine but flucytosine is expensive and unavailable where most disease occurs. More effec...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Wiley
2019
|